Skip to Main Content

Advertisement

Skip Nav Destination

Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab—Response

Clin Cancer Res (2020) 26 (10): 2436.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Linglu Wang
  • Xiaoyan Liu
  • Yuhang Han
  • Hsiang-i Tsai
  • Zilin Dan
  • Peiru Yang
  • Zhanxue Xu
  • Fan Shu
  • Chao He
  • John E. Eriksson
  • Haitao Zhu
  • Hongbo Chen
  • Fang Cheng
Cancer Letters (2024) 590: 216861.
  • Ana Ruiz-Garcia
  • Paul Baverel
  • Dean Bottino
  • Michael Dolton
  • Yan Feng
  • Ignacio González-García
  • Jaeyeon Kim
  • Seth Robey
  • Indrajeet Singh
  • David Turner
  • Shu-Pei Wu
  • Donghua Yin
  • Di Zhou
  • Hao Zhu
  • Peter Bonate
Journal of Pharmacokinetics and Pharmacodynamics (2023) 50 (3): 147.
  • Cody J. Peer
  • Sara M. Zimmerman
  • William D. Figg
  • Daniel A. Goldstein
  • Mark J. Ratain
Clinical Pharmacology in Drug Development (2022) 11 (1): 134.
  • Kathryn Chen
  • Joel Yong
  • Roland Zauner
  • Verena Wally
  • John Whitelock
  • Mila Sajinovic
  • Zlatko Kopecki
  • Kang Liang
  • Kieran Francis Scott
  • Albert Sleiman Mellick
Cancers (2022) 14 (22): 5564.
  • Kyung-Soo Chun
  • Do-Hee Kim
  • Pawan Kumar Raut
  • Young-Joon Surh
Seminars in Cancer Biology (2022) 86: 1008.
Close Modal

or Create an Account

Close Modal
Close Modal